I. INTRODUCTION
Imagine the frustration of having a child with a disability, knowing there is a potentially life-changing treatment available but being unable to provide it-because it costs over $70,000 a year and is not covered by insurance. To what lengths would you go to provide this treatment for your child, even if it does not turn out to be the magic bullet you were hoping for? Would you take out a second mortgage on your house? Would you exhaust your savings or cash in your retirement accounts? For many parents of children with Autism Spectrum disorders ("ASDs"), this is their reality.
ASDs describe a range of complex neurological disorders characterized by marked impairments in communication and social relatedness and the presence of restricted repetitive or stereotypic patterns of behavior, interests or activities. 1 ASDs include autistic disorder, Asperger's syndrome, INDIANA HEALTH LAW REVIEW [Vol. 8:2 autism insurance reform laws. 8 Furthermore, there is a proposed federal insurance mandate included in the Autism Treatment Acceleration Act of 2009 ("ATAA"), currently referred to the Senate Health, Education, and Labor Committee, that would require states to mandate coverage for medically necessary therapy for individuals with ASD. 9 The goal of this Note is to provide a summary of issues leading to the enactment of autism insurance reform, compare current state initiatives, and identify potential concerns in current legislative language. The first section provides a background on ASDs, including treatments, costs, and the current system for providing services. The next section provides a background on the health insurance industry's treatment of ASDs that led to the development of autism insurance reform. It includes information on riskshielding techniques used by the industry and available consumer protection tools. The third section presents current state and federal autism insurance initiatives and specifically examines common provisions and controversies surrounding autism insurance mandates. The final section identifies problems with the current state and federal autism insurance reform initiatives and offers suggestions for addressing those issues.
II. BACKGROUND
A. Autism Spectrum Disorders
Diagnosis, Symptoms, and Prevalence
Autism is a complex neurological disorder characterized by marked impairments in communication and social relatedness and the presence of restricted repetitive or stereotypic patterns of behavior, interests or activities. 10 Autism is on the lower end of a spectrum of Pervasive Developmental Disorders ("PDDs") with Asperger's syndrome at the high end and Pervasive Developmental Disorder, Not Otherwise Specified ("PDD-NOS") typically somewhere in the middle.
11 These three separate diagnoses are often referred to as Autism Spectrum Disorders ("ASDs"). 12 ASDs are di- 12. Id. Autism Spectrum Disorders is a colloquial term used to describe the three most common PDDs, however, the term will likely be adopted as the medical term in the next agnosed by physicians, psychiatrists, or clinical psychologists through observational methods and interviews with the child's caregivers; 13 there are currently no approved medical tests to accurately confirm a diagnosis.
14 Despite their conceptualization as points on the same spectrum, there are important differences among the three ASD diagnoses. Asperger's syndrome differs from autism because with Asperger's syndrome there is no delay in language or cognitive development. 15 Because people with Asperger's syndrome have marked impairments with social interactions, many children are not diagnosed until they reach grade school age when social problems become more apparent. 16 Children with autism, on the other hand, must have symptoms present prior to age three but can be identified as early as two years old.
17 PDD-NOS requires that there be impairment in reciprocal social interaction with an impairment in communication skills or the presence of stereotyped behaviors, interests, or activities, but some criteria of typical autism may be lacking, such as a late onset of symptoms or failure to meet all the three symptom clusters.
18
Each person with ASD presents with an individualized pattern of behaviors or impairments making a large number of symptom presentations possible. The severity of these disorders varies along a continuum, with some individuals having more profound problems in one key diagnostic area than others. ASDs are associated with the full range of cognitive abilities, from profoundly mentally impaired to exceptionally bright.
19
In addition to the diagnostic symptoms, individuals with ASD often have underlying co-morbid health issues. 20 Seizures affect as many as twenty-five percent of individuals with ASD. 21 Additionally, many individuals experience anxiety, depression, sensory disturbance, hyperactivity, attention-deficit, gastro-intestinal problems, ear infections, allergies, and edition of the DSM. The other PDDs, Rett's disorder and Childhood Disintegrative Disorder ("CDD"), are less common and not currently considered part of the autism spectrum. However, DSM-5 proposes to phase out Rett's disorder altogether as a PDD and include CDD as an ASD.
13. See, e.g 
., Catherine Lord et al., Autism Diagnostic Interview-Revised: A Revised Version of a Diagnostic Interview for Caregivers of Individuals with Possible Pervasive
Developmental Disorders, 24(5) J. AUTISM & DEV. DISORDERS 659, 660 (1994) , available at http://infantlab.fiu.edu/articles/ Lord,Rutter,LeCouteur_1994%20JADD.pdf.
14. Despite the reliance on observation and interview, the use of Magnetic Resonance Imaging ("MRI") to diagnose autism is possible in the near future. sleep disorders. 22 Due to the wide range of additional medical problems associated with ASD, access to medical care is important.
ASDs affect every race, ethnicity, and socioeconomic status. However, ASDs increasingly affect males compared to females. 23 In 2000, it was estimated that between two to and twenty children out of every 10,000 had autism. 24 In 2006, the Centers for Disease Control estimated that one out of every one hundred children has an ASD. 25 The prevalence of ASDs is increasing dramatically in every state, 26 each lacking an adequate system to support their needs. 
Treatments
There is no cure for autism. 28 However, with intervention, many individuals with ASD can make significant improvements in decreasing symptoms and living independently.
29
There are several recommended interventions for ASDs including behavioral, speech, occupational, and physical therapy, as well as medications to address symptoms associated with ASDs.
30
A commonly prescribed treatment protocol, and the most controversial in the fight for insurance coverage, is Applied Behavior Analysis ("ABA"). ABA is a toolbox of behavioral modification principles based on theories of learning and operant conditioning. 31 The goal is to reinforce appropriate behaviors like communication, socialization, and self-help skills, and decrease problem behaviors like stereotyped or repetitive movements, self- Researchers have successfully posited several models of ABA interventions. 33 While the core behavior modification principles remain the same, the intensity, frequency, duration, setting, and therapist characteristics may change based on the intervention model used. Researchers are still working to find the right combination of factors that produce the best results. However, all agree that early intensive intervention is key to compounding the positive effects of any ABA therapy model.
34
With early intervention, children with autism have shown improvements in IQ, language, academic performance, adaptive behaviors, and social skills.
35
One intervention model with demonstrated success involves intensive treatment requiring thirty to forty hours of therapy a week for several years. 36 Half the children treated with these intensive behavioral intervention models can overcome their autistic characteristics such that they are indistinguishable from their peers. 37 Recently, researchers at the Center for Autism and Related Disorders found that forty-three percent of children with autism participating in their study who received an ABA-based program consisting of at least twenty-five hours per week of treatment no longer displayed clinical symptoms of autism and demonstrated improvements in functioning.
38
Because ABA therapy involves a great deal of time, it is quite expensive and most medical insurance policies do not cover it. 39 Wealthy parents may pay thousands of dollars a year 40 (May 11, 2010, 9 :02 AM CDT), http://www.dallasnews.com/sharedcontent/dws/news/city/ collin/plano/stories/051110 dnmetautism.41d0d68.html (reporting that parent pays $5,000 per month for ASD services); PENNSYLVANIA HB 1150, supra note 39, at 13 (quoting a parent who spent approximately $600,000 in ASD services in the past twelve years).
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41
Without early intensive ABA therapy, children with ASD are likely to place a large financial strain on the state through placements in costly special education programs or institutionalization in state hospitals.
42

The Cost of Autism
The societal cost of autism is estimated at $35 billion to care for all individuals with autism over their lifetime. 43 This cost is driven by both direct and indirect costs. 44 Direct costs are incurred, like any child, through expenses associated with routine medical and dental care. 45 However, children with ASD use health care services more frequently than typically developing children and are responsible for higher health care costs.
46
Indirect costs associated with ASD include lost productivity by parents who may reduce the hours they work outside the home or forego outside employment entirely to care for their child.
47
Indirect costs also include productivity lost for adults with ASD who are unable to work.
48
These costs have enormous ramifications for society's tax base as children with ASD transition into adulthood. If a child with an ASD is not properly treated, the societal cost for that one child over his or her lifetime could be as high as $3.2 million. 49 The costs associated with caring for an individual with ASD have led many states to sponsor treatment programs through public schools and Medicaid waiver programs.
41. See S. 127, Gen. Assemb., Reg. Sess. (Vt. 2010) § 1(4) (reporting on a survey which found that approximately fourteen percent of children with an ASD had foregone care, thirty-eight percent of families of children with an ASD had financial problems caused by their child's health care, and thirty-five percent of families noted needing additional income to cover medical expenses).
42. 
B. State-Sponsored Services
Traditionally, states provide services to individuals with ASD through various agencies and state-funded programs. These services are expensive. For example, in 2009, Indiana's Bureau of Developmental Disabilities Services ("BDDS"), the state agency responsible for administering services, spent approximately $536 million on services for individuals with ASDs and other developmental disabilities. 50 Consequently, the increased prevalence of ASD coupled with dwindling state budgets has created a system that cannot possibly support the burgeoning need.
Early Intervention Services and the School System
Under the 2004 reauthorization of the Individuals with Disabilities Education Act ("IDEA"), early intervention and special education programs must provide services and treatments to children with ASDs.
51 Early intervention programs typically include children from birth to three years old who have a developmental delay. 52 In 2009, Indiana served approximately 10,000 children at an estimated cost of $34 million in its early intervention program. 53 Unfortunately, because services stop at age three, many children with autism who are unable to be diagnosed until approximately eighteen months old cannot take advantage of these types of programs for very long, if at all.
With respect to the school setting, IDEA only requires services when the child's exceptionalities affect his or her ability to receive an education. 54 Therefore, higher functioning children or children with Asperger's syndrome, for example, would likely be excluded from receiving treatment through the school. Additionally, problems associated with treating individuals with ASD are too numerous to be dealt with through the public school system alone. 55 tremendous waiting lists, it is unlikely an individual will get a Medicaid waiver during the period immediately following diagnosis when intervention would be most effective.
Aside from the limited number of individuals the waivers are able to assist, 64 the services provided to those who qualify are often deficient in quality of personnel and standards of care. Medicaid suffers from low reimbursement rates, which makes it difficult for many organizations to retain qualified service providers. 65 Moreover, services accessed through the Medicaid system are often inadequate to meet the specific needs of a child with autism.
66 For example, a Pennsylvania panel reviewing the need for autism insurance reform noted that, "Pennsylvania's Medicaid waiver program is fragmented, does not cover all of those in need, and has inadequate payment schedules for at least some providers and specific services." 67 Therefore, while Medicaid waiver programs offer much needed assistance, they often help too few and are inundated with problems.
68
To summarize, ASDs are complicated disorders with a dramatically increasing prevalence rate and expensive treatments that cannot be supported by the current state-funded systems. Faced with such a dire situation, many states explore alternative methods of providing services to its citizenry -in this case, health insurance.
C. Health Insurance and Autism
Individuals with ASD may seek insurance coverage through a variety of means. Children with ASD are likely to enroll as dependents on their parent's health insurance plan or under state-sponsored health insurance programs.
69 However, as adults, individuals with ASD would be able to continue coverage under their parent's health insurance plan only if they are 64. See, e.g., Bisbecos, supra note 50, at 7 (noting that a total of 11,109 individuals receiving waiver services with only 7,093 receiving comprehensive waiver services).
65. AUTISM SPEAKS, ARGUMENTS, supra note 4, at 8. considered a legal and disabled dependent. 70 If the individual does not qualify for Medicaid or receive benefits through an employer, the only option available is for individual coverage.
Because individuals with ASD use a disproportionate amount of health care services, insurance companies have historically attempted to minimize the risk associated with providing coverage for this group.
71
There are two main ways insurers exclude people with ASDs from coverage: (1) through enrollment practices; and (2) through limitations and exclusions in the terms of coverage. 72 
Enrollment
Typically, when a person applies for individual health insurance coverage, the company goes through an underwriting process to evaluate the risk posed by insuring that individual.
73 Some people are considered too big a risk to be permitted to enroll, or may enroll only under pre-existing condition exclusions designed to protect the group from expensive health conditions present at the time of enrollment.
74 Pre-existing condition exclusions allow enrollment while imposing total exclusions for pre-existing conditions or, in some cases, waiting periods for coverage of pre-existing conditions. 75 For individuals with an ASD, this means that they may have more difficulty obtaining coverage, would only be covered for medical services not associated with their diagnosis, or if subject to a waiting period, would have to wait a specific period of time before receiving coverage.
76
With the recent health care reform, insurers may be prohibited from exclud- Individuals with autism who are permitted to enroll may be charged higher premiums. 78 Underwriting permits the adjustment of premiums to reflect the anticipated level of financial risk.
79 Individuals whose characteristics (i.e., health status and personal characteristics that predict health status and insurance use) pose higher financial risks would pay a higher premium. Sometimes charging a significantly higher premium is enough to render coverage unaffordable, thus, constructively barring someone from enrolling. Fortunately, as discussed below, autism insurance mandates include a provision prohibiting insurance companies from charging a higher premium solely because the individual has an ASD. 80 However, laws aimed at disabling a company's ability to control financial risk at the point of enrollment can lead to an increased use of risk-shielding tools in the policy's terms of coverage. 
Coverage
Post-enrollment risk-shielding limits the amount, duration, or scope of coverage. There are several ways that insurance companies have avoided covering services for individuals with ASD including: treating ASDs as non-medical conditions; finding treatments to be experimental, educational, not medically necessary, or habilitative in nature; or denying claims because there is no qualified provider.
a. ASDs as non-medical conditions
As a threshold matter, insurance companies are historically unsure how to deal with autism as a diagnosis. Some classify it as mental illness, which would place it under mental health coverage. 82 Others classify it as a chronic illness, placing treatments in the long-term care category. 83 The designation is important in determining whether ASDs are covered at all, as some health plans do not offer coverage for mental health or long-term disability. 84 Even when ASD's designation as a medical condition is not in question, there are other ways insurance companies attempt to exclude coverage. One way is to deny coverage for ASDs based on the person's diagnosis. 87 For example, in Illinois, an insurance carrier denied coverage for speech therapy because the plan excluded therapies for conditions of developmental delay, learning or educational problems, and non-restorative medical conditions even though speech therapy would be available to treat other conditions. 88
b. ASD treatments
Another way insurance companies attempt to avoid paying claims for ASD treatment is by focusing on the treatment or the provider. Insurance companies have an arsenal of tools for denying coverage for services to treat ASD symptoms, many of which are discussed below.
(I) Treatment is experimental
To promote the use of effective, scientifically valid treatments, insurers may limit coverage to evidence-based treatments. Because of the extreme variability in symptom presentation for individuals with ASDs, efforts to identify treatments that meet the health insurance industry's standards for evidence-based treatments are difficult for researchers to achieve. Insurance companies argue that autism is an individually based disorder, and so there is often no clear standard of care.
90 Therefore, health insurance carriers that provide coverage for autism may classify certain therapies as "experimental and investigational," thereby excluding those 
(II) Treatment is not medically necessary
Another way insurance companies attempt to avoid coverage for ASD is to determine that the therapies are not medically necessary. 93 Plans differ in the precise language but generally, medically necessary services are those that the plan's administrator considers appropriate for the treatment and diagnosis of a covered illness. 94 Insurers may deny coverage for therapies based on a lack of medical necessity even if a treating physician prescribes the service.
(III) Treatment is habilitative, custodial, or maintenance
Sometimes services available for medical conditions in the short-term are excluded for use as long-term therapy for individuals with ASD. 96 One justification for excluding ASD treatments otherwise covered for other conditions is that insurers do not believe such therapies have a "reasonable expectation of achieving sustainable, measurable improvement in a reasonable and predictable period of time."
97 When restoration of previous functioning is required, it automatically eliminates the "potential for covering treatments whose medical purpose is to help a patient attain, maintain, or avert the loss of functioning. (IV) Treatment is considered "educational"
Another way insurers deny coverage for some ASD treatments is by categorizing the treatments as educational. 99 States are required to provide certain services, including ABA and other therapies, if it will help the individual receive an education.
100 Therefore, insurance companies have historically not covered services that are available through the school. Speech and ABA therapy are typical targets for exclusion as educational interventions. 101 For example, Aetna's description of ABA therapy stresses the role of education and identifies it specifically as an excluded educational intervention.
(V) No qualified in-network providers
Another way insurance companies are able to deny coverage for ABA in particular is to deny the treatment because it is not administered by a qualified or credentialed provider. 103 The bulk of intensive ABA therapy may be administered by an unlicensed, uncertified provider (typically a college student, recent college graduate, or parent), with a certified provider overseeing the treatment. 
Consumer Protection Tools
Insurers draft the insurance contract in such a way that they retain broad discretion over whether to approve or deny coverage. 107 When an insurer denies coverage, the company is required to let the insured know the reason for the denial. 108 To challenge a denied claim, the consumer can appeal through the company's internal grievance process.
109 Indiana's Department of Insurance as said that the internal review, when related to ASD services, must be done by a physician with expertise in ASDs.
110 Because the burden of proof lies with the consumer to show why the claim is a covered service, fighting a denial can be difficult and frustrating.
111 If the consumer is still not satisfied after exhausting the company's internal grievance process, he or she may file a complaint with their state agency that regulates insurance or seek a remedy through the court system.
112
In addition to licensing health insurers, states also regulate the insurers' finances, market conduct, policy forms, rules regarding access to coverage, required benefits, premiums, renewability, provider network arrangements, and consumer complaints.
113 State insurance regulators can serve as intermediaries to resolve specific conflicts. 114 In addition, state insurance regulating agencies can facilitate an external review by a panel of independent medical experts.
115 However, the external review process may only be available for specific denials. However, while courts may offer protection for consumers, the time, money, and resources needed to pursue litigation against an insurance company is not something many people can afford.
123
To summarize, insurance companies have denied coverage to individuals with ASD under many different plan exclusions. The current process to challenge denials, while moderately successful, is time consuming and may be costly. One solution to the inadequate state-sponsored services and the insurance industry's treatment of autism gaining popular support is autism insurance reform.
D. Autism Insurance Reform
Mandates are laws that require state-licensed health insuring organizations to offer or include coverage for certain benefits or services. 124 One of the latest state legislative trends is to enact a stand-alone autism insurance mandate that covers treatments specifically for ASDs. 125 The ASD insurance mandate recognizes the demand for coverage of services to children with an ASD and attempts to eliminate previous benefit exclusions. 126 Currently, twenty-three states require insurance coverage for the treatment of ASDs.
127 Indiana enacted the first meaningful autism insur- 
Current State Autism Insurance Mandates -Common Provisions and Definitions
The wording for autism insurance mandates is intentionally broad because ASD affects each person differently and requires individualized treatment. 130 The various provisions for the different state statutes can be broken down into eight areas.
a. Covered persons
States vary on both the ages and diagnoses covered by the statute. Most states limit the age range for which coverage is required.
131 Age limits typically cover the person through school age, but a few states restrict coverage to younger children. 132 Currently, only Indiana, Massachusetts, 
b. Covered services
Autism advocates argue that model legislation should include coverage for diagnosis and assessment, ABA therapy, speech, occupational, and physical therapy, psychological care, psychiatric care, and pharmaceutical care.
139 Indiana allows for broad coverage of ASD services, so long as those treatments are medically necessary and prescribed by a physician through a treatment plan. 140 To combat the difficulty many families face in accessing ABA in particular, some states have mandated coverage just for ABA and therapeutic services. 141 Many states further clarify that treatment specifically includes diagnosis, behavioral therapy (including ABA), prescription drug therapy, psychiatric care, psychological care, and therapeutic care (including speech, occupational, and physical therapy). 142 However, plans that do not offer coverage for certain services to any member, like prescription drug coverage, are not required to provide such services just for those members with ASD. 143 Coverage of autism services may be subject to other general policy exclusions and limitations such as coordination of benefits, participating provider requirements, or prohibiting reimbursement for services provided by family or household members. 144 To combat denials based on an insurer's determination that a treatment like ABA is experimental, several states have specifically defined the treatments listed in the statute as evidence-based. 145 Further complicating matters, a few states have included language within their autism insurance reform legislation that reaffirms the state's obligation to provide services through early intervention programs and public schools while allowing insurers to exclude coverage for services received under IDEA laws when provided in the school context. However, insurers may still have to provide coverage for those services when done outside the classroom. 146 The uncertainty between what constitutes special education, which would be covered by the schools under IDEA, and what constitutes medical therapy creates a grey zone that could result in children being denied coverage by both their school districts and their insurance companies. 147 
c. Covered providers
For quality control purposes, insurers require covered services to be rendered by qualified providers, who at a minimum are licensed in the state where they practice. 148 However, ABA providers, while able to get national certification, are slow to be recognized or licensed within a state. 149 Indeed, some autism insurance mandates do not specifically include certified ABA therapists as covered providers. 150 To address this issue, some states allow nationally certified behavior therapists to provide treatment. 151 Other states address the problem by creating a category of Autism Service Providers, which include ABA therapists and other providers with specific knowledge and experience with ASDs.
d. Treatment plans
Several states require a treatment plan to be submitted to the insurance company. 153 The treatment plan must include all elements necessary for the insurer to properly pay claims. 154 These elements generally include the in- dividual's diagnosis, a list of proposed treatments including: the frequency, duration, and likely outcomes for each; the frequency by which the treatment plan will be updated; and the treating physician's signature. 155 The treatment plan allows several different professionally accepted therapies to address ASD symptoms without having to seek individual approval for each service. 156 States differ on who may develop and who must sign the treatment plan. Some states allow any qualified provider to develop and sign the treatment plan, 157 while other states limit the task to only certain providers. 158 Finally, a few states specifically require a physician to develop and sign the treatment plan. 159 The insurance company has a right to periodically review the treatment plan to determine whether the services ordered are medically necessary. 160 Some states condition the insurer's review process by requiring a specialist in the treatment of ASDs to review the plan. 161 Even without requiring a formal treatment plan, some autism insurance mandates give the insurer the ability to conduct periodic reviews of whether a treatment continues to be medically necessary. 162 
e. Maximum benefit amounts
Only a few states, Indiana, Massachusetts, Texas and Vermont, do not place maximum yearly benefit limits on ASD services. 163 However, most states set an annual maximum benefit amount for ASD services; sometimes this limit just applies to ABA.
164 Some states lower the yearly maximum benefit as the child gets older. 165 For example, Arizona allows benefits up to $50,000 per year for a child under the age of nine but decreases that amount to $25,000 per year for a child ages nine to sixteen. 166 This tiered approach emphasizes the need for early intensive therapy while constraining the overall costs associated with treating a child with an ASD. Table 2 presents a summary of maximum benefit amounts by state. surers may be required to go beyond what they provide for other users of certain services. For example, where speech therapy may be limited to a certain number of sessions for illness in general, speech therapy visits for individuals with ASD may not be limited when the treatment is prescribed as medically necessary.
g. Prohibiting termination or refusal to renew a policy
As previously discussed, insurance companies may have blanket exclusions for ASDs. 169 Most autism insurance mandates prohibit blanket exclusions by providing that, "an insurer may not deny or refuse to issue coverage on, refuse to contract with, or refuse to renew, refuse to reissue, or otherwise terminate or restrict coverage on an individual under an insurance policy solely because the individual is diagnosed with an ASD." 170 
h. Types of insurance plans affected
There are several mechanisms for accessing health insurance. By far the most common is through employer-sponsored plans. 171 Two primary ways employers provide access to coverage is through self-funded plans or group benefit plans. Self-funded insurance policies are typically offered to employees by large companies or government employers. 172 The employer pays the employees' health care costs from its own pocket and assumes the risk that it will be able to cover all its employees' health care needs. 173 Because these self-funded plans are not actually insurance, states generally cannot regulate their content or activities and, therefore, cannot require them to offer any specified benefits. 174 This means that states cannot re-to provide ASD coverage. 185 Therefore, employees of larger companies with locations nationwide may find it difficult to determine whether their health plan is covered by an ASD mandate, as the employee's state may differ from the company's headquartered state on ASD coverage.
When people do not have health insurance through their employer, they may purchase an individual health insurance policy. Individual policies are often more expensive because there is not an associated group to pool the risk.
186 Like small-group plans, states will sometimes exempt individual plans from the ASD mandate. 187 However, a few states require insurers selling individual policies to offer the option to include coverage for ASD using a rider, which allows the consumer to purchase the coverage as an option with a corresponding increase in premiums.
188 Table 3 presents a summary of plans covered by autism insurance mandates. 189. As definitions of insurance plans may vary slightly by state, readers are encouraged to visit their state's insurance regulatory body to determine what types of plans are available and to confirm whether their particular plan is covered by the mandate. This table serves merely as a broad overview. "Small Group" refers to plans with less than fifty enrollees, "State-Sponsored" refers to state sponsored health insurance programs like Children's Health Insurance Programs ("CHIP") or expansion to Medicaid coverage. Arizona's statute applies to group insurance provided by a hospital or medical service corporation plan. Kansas' legislature is studying the effect of the mandate on state employee plans before determining whether it should be expanded to private insurers. KAN. STAT. ANN. § 75-6524(c)(2). Texas requires state mandated plans to cover ASD treatments, and it is unclear which specific plans will be covered. 
Autism Treatment Acceleration Act of 2009 ("ATAA")
The Autism Treatment Acceleration Act of 2009 ("ATAA"), if enacted as proposed, would require both self-insured group plans and individual health plans to provide coverage for the diagnosis and treatment of ASDs. 190 Further, ATAA would require every state to mandate coverage for ASDs.
191 Current ASD mandate statutes that do not meet the minimum set by the ATAA may be preempted and the ATAA will govern.
192 How-190. ATAA, S. 819, 111th Cong. § 12 (2009) (amending ERISA 29 U.S.C. 1185). The bill stalled in committee. However, for purposes of analysis, this note addresses the general text and spirit of the bill since it is possible that the bill could be reintroduced in the next session.
191. ATAA, S. 819, 111th Cong. § 12 (2009). 192 . It is unclear how the ATAA will preempt state statutes, either in total or by provi-ever, states with autism insurance mandates that meet the standards set out in the ATAA will not be preempted. 193 Similar to Indiana's mandate, the ATAA does not have age restrictions or maximum benefit amounts. 194 Interestingly, the ATAA does not tie diagnostic eligibility to the DSM, and it includes all PDDs for the section amending ERISA but only ASDs for the section amending PHSA. 195 The ATAA does not require a treatment plan and allows a wide range of professionals to order treatment, so long as the treatment is medically necessary. 196 The ATAA lists several covered services, including diagnosis, ABA, pharmacy care, psychological and psychiatric care, and therapeutic care. 197 The ATAA prohibits covered plans from denying coverage on the basis that the service is necessary to develop, maintain, or restore skills or functioning or to prevent loss of skills or functioning. 198 State, local, and tribal government health plans would generally be covered by the ATAA. 199 However, a state, local, or tribal government employer that provided its employees with self-funded health plan coverage could opt out of the ATAA's requirements, just as self-funded state, local, and tribal government health plans can opt out of other federal insurance mandates. 200 
E. Controversies and ASD Insurance Reform
Underlying the push for ASD insurance reform is a debate among autism advocates, the state, and the insurance industry regarding who should pay for ASD services, and what the real impact of an ASD mandate will be. medical doctor or a clinical psychologist diagnoses ASDs and those providers prescribe treatment, ASDs should be considered medical conditions covered by health insurance.
213
Financial Impact of ASD Insurance Reform
The debate about whether health insurance should ultimately be responsible for covering the cost of ASD treatments or whether states should reform their service delivery systems will continue. However, the reality concerning an ASD mandate's effect on premiums is not something legislators can easily ignore. While ABA is an expensive treatment, many argue that failure to provide such treatment would result in greater long-term societal costs. 214 In response, opponents argue that the premium increase required to pay for this added coverage could force more people to drop insurance coverage, which may also result in increased societal costs. 215 Balancing the long-term savings to taxpayers against the immediate impact on premium rates is not easy for a legislator to do when faced with angry voters on both sides of the controversy.
Supporters of autism insurance reform point to the estimated cost saving to taxpayers through reduced use of state-sponsored social services across the individual's lifespan. 216 The estimated cost of providing statesponsored services is extraordinary and decreases resources available to address the needs of other citizens. 217 While early behavioral intervention does not guarantee success for all, it does decrease the likelihood that individuals with ASD will need prolonged care throughout their life.
218 Lack of early intervention limits the number of individuals with ASD who are able to achieve higher levels of functioning; thus, indirectly affecting public schools and Medicaid services, which are required to provide specialized education and more intense psychiatric treatment.
219
Beginning with the first autism insurance mandate enacted in 2001, states have come to realize the long-term benefits of requiring insurance carriers to cover ASD services. For example, the Pennsylvania Commonwealth Insurance Department estimated that Medicaid could save $16.5 to $22.2 million in the first year following the adoption of ASD insurance reform. 220 In contrast, funds once spent on services for ASD may be merely INDIANA HEALTH LAW REVIEW [Vol. 8:2 shuffled into another funding category, leaving taxpayers without a reduction in spending. ASD insurance reform supporters even suggest that mandates can save insurance providers money. Mandated services that are preventive in nature can mitigate other long-term health costs, thereby justifying the initial cost of the mandate. 221 For example, the use of ABA can save insurance companies money over time by reducing the need for expensive inpatient hospitalizations.
222
On the other hand, while mandates make health insurance more comprehensive, mandates also make it more expensive, as insurers must now pay for care consumers previously funded out of their own pockets. 223 Like states, insurance companies are concerned about the rapid increase in the number of individuals with ASD and how that will affect the companies' ability to keep premiums affordable.
224 ASD insurance reform is estimated to add approximately one percent to premium costs. 225 The Indiana Legislative Services Agency estimates that Indiana's ASD mandate increases premiums by $0.44 to $1.67 per member per month. 226 Advocates argue that for only a modest effect on premiums, ASD insurance reform holds the promise of significantly improving the lives of thousands of children. 227 As an additional guard against rapid premium increases following introduction of an ASD insurance mandate, Massachusetts allows insurers, corporations, or HMOs to seek exemption from the requirement to cover ABA for three years if the entity can show that including the treatment would exceed one percent of the premiums charged. 228 Following the three year period, the entity would be required to cover ABA. 229 While a program like this delays the availability of ABA for families, it would allow the entity to gradually increase its premiums across a three year time span, rather than increasing premiums in one large lump sum.
Insurers argue that the problem is not just with the autism mandate, but includes the accumulated effects of multiple mandates that price many people out of the market. 230 The number of mandates differs by state. Idaho has the lowest number of mandates at thirteen; Rhode Island has highest at seventy, whereas Indiana has thirty-four mandates. 231 The insurance industry lobby notes that mandates require insurers to pay more claims, and eventually they must raise premiums to cover those costs. 232 Opponents argue that mandated benefits increase the cost of basic health coverage from twenty to fifty percent, depending on the number of mandates, the benefit design, and the cost of the initial premium. 233 That additional cost may be the determining factor in whether or not a person can afford health insurance. 234 When health insurance costs increase, more people, especially healthy people, drop or decline coverage leading to adverse selection. 235 Adverse selection occurs when less healthy people disproportionately enroll in a risk pool with a low number of healthy people. 236 Therefore, mandates that drive up the cost of health insurance may lead younger and healthier people to cancel their coverage, leaving the pool smaller and sicker. 237 To summarize, the main controversies surrounding ASD insurance reforms focus on who should be financially responsible for providing services to individuals with ASD. While both states and insures recognize the benefits of ASD services, neither wants to be responsible for their enormous cost. States, looking to reap the benefits of long-term savings to public services, have shifted the responsibility to private insurers through ASD insurance reform. But is ASD insurance reform working?
III. ANALYSIS
A. ASD Insurance Mandates
Even though insurance mandates help address some of the ways insurers deny coverage for ASD treatments, the problems persist. Since many ASD insurance mandates are just being implemented, there is not much data available on how well the mandates are working to ensure access to services for individuals with ASD. Kansas and Missouri have built in to their legislation requirements for ongoing study of the effects of autism mandates on quality of services, associated costs through increased premiums, and savings realized by tax-payer funded programs. 238 More states should en- Vol. 8:2 courage the collection and analysis of this type of information because without this information, one cannot adequately determine the effect these mandates have on both the families of children with ASDs as well as the cost to the general public. However, based on the common provisions discussed above, several issues may pose problems as consumers request services covered under ASD insurance reform measures.
Covered Persons a. Age
Both Florida and South Carolina require a diagnosis prior to a certain age to qualify for ASD benefits. 239 Restricting the age for when a child must be diagnosed places a burden on families to seek a diagnosis quickly. This requires families to be cognizant of any developmental delays in their child and be motivated enough to seek assistance from a doctor. Moreover, it requires primary care physicians to acknowledge the parents' concerns and make appropriate and timely referrals to specialists, who may have lengthy waiting lists. For individuals with Asperger's syndrome, who generally receive a diagnosis later in childhood, baseline age restrictions have the potential to exclude them completely from mandated benefits.
Early detection and intervention are critical to the ultimate functioning level of people with ASDs. However, ASD mandates that cap the age at which benefits may be received ignore the continuing challenges faced by individuals with ASD. 240 The National Institute of Child Health and Human Development notes that, "[i]t is never too late to benefit from treatment. People of all ages with ASDs at all levels of ability generally respond positively to well-designed interventions."
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Costs are an important consideration, and restricting the age for which ASD mandates apply is one way to reduce costs. However, states should be aware of the potential societal costs associated with denying coverage to older adolescents and adults with ASD compared to any immediate cost savings realized with age restrictions.
b. Diagnosis
Several states restrict the diagnoses covered under their mandate to mine whether the mandate should be expanded to private insurance plans); MO. ANN. STAT. § 376.1224(19) ASDs only. 242 While most states tie coverage to the most current edition of the DSM, other states either tie coverage to a specific edition of the DSM or do not tie coverage to the DSM at all. 243 Indeed, the ATAA language as it stands does not relate eligibility to the DSM. 244 The next edition of the DSM is set to for release in 2012 and will likely reflect a dramatic shift in diagnostic conceptualization. 245 Disorders like Asperger's syndrome and PDD-NOS will cease to exist as independent disorders but will instead be covered under the broader designation, Autism Spectrum Disorders. 246 It is unclear how this change will affect statutes tied to current DSM diagnostic categories. For statutes that limit coverage to only certain diagnoses but tie the definition to the current version of the DSM, the change has the potential to broaden the scope of individuals covered under the mandate. However, statutes that list covered diagnoses but do not tie coverage to the DSM risk confusion as diagnoses like PDD-NOS and Asperger's syndrome fade from use. Finally, statutes that refer to diagnoses in a specific edition of the DSM risk confusion in determining whether individuals diagnosed under the new diagnostic criteria fit the old definitions referenced in the statute. It is unclear whether insurers would deny coverage based on an old diagnosis, require a new diagnosis using new criteria, or challenge the applicability of the mandate to a class of people previously not covered. To avoid these problems, legislators should amend autism insurance reform legislation definitions to cover both the old diagnoses as well as the new. 247 Furthermore, state insurance regulating agencies should be encouraged to develop appropriate guidelines and to collaborate with both providers and insurers to ensure that transition to a new diagnostic system does not disrupt services.
Covered Services
Compared to other disorders, research into treatments for ASD is in its infancy. Fortunately, most ASD mandates specifically outline what treatments are to be covered, thereby reducing the likelihood of those services 247. For example, the following language could be used where the list of inclusive diagnoses could be modified to include only those populations intended by the legislature to be covered under the mandate: "Autism Spectrum Disorders means any of the following disorders as defined by the DSM edition in force when the diagnosis was made: Autistic disorder, Asperger's syndrome, Pervasive Developmental Disorder, Not Otherwise Specified (PDD-NOS), Childhood Disintegrative Disorder (CDD), Rett's Disorder, or Autism Spectrum Disorder (ASD)." sumer protection. Second, recognition of national certification would encourage more people to become therapists. This would allow market forces to reduce the costs of ABA through the increased availability of providers and competition. Finally, once ABA therapists attain qualified provider status, insurers would be able to bargain for reduced rates by including those providers in their network.
Even when a state does not recognize ABA therapists for state licensing purposes, there are ways to ensure treatment is not being denied due to the lack of a credentialed provider. For example, the Indiana Department of Insurance has said that despite its lack of state recognition for ABA therapists, "It is . . . inappropriate at this time for an insurer to deny a claim based upon the fact that the provider of ABA does not hold a license." 257 Indeed, in the absence of state licensing, allowing insurers to deny claims based on a lack of state licensure would allow insurers to avoid paying for ABA altogether. 258 One unique solution gaining popularity is the concept of Autism Service Providers. 259 This approach allows states to define the appropriate scope of professionals, licensed or not, who are qualified to provide services to individuals with ASD. This ensures not only a certain level of oversight by the state, but also recognizes the importance of having providers who are trained and experienced in the unique challenges associated with treating individuals with ASD. Indiana, along with other states, lag in recognizing nationally certified ABA therapists and would do well to either grant state licensure for ABA therapists, 260 or to amend the autism insurance mandate to include a category of Autism Service Providers.
Treatment Plans
Several states require a treatment plan as part of the ASD insurance mandates. 261 States requiring treatment plans as a condition of coverage should clearly outline who is allowed to develop the plan, who must sign the plan, and the necessary elements. For example, insurers under the Indiana mandate were requiring the individual's primary care physician to sign even though he or she had not participated in the plan's development, which made these physicians understandably uncomfortable. 262 The Indiana Department of Insurance, thus, clarified its guidelines to indicate that the treating physician, rather than the primary care physician, could sign off on the the mandate.
270 Nationally, Autism Speaks estimates that approximately two-thirds of employees of state, local, and tribal governments are enrolled in self-funded health insurance plans. 271 Given that so many people are covered under self-insured plans, an ASD mandate does not lead to providing substantially more people with a given benefit. 272 Many ASD insurance statutes also exclude individual policies or small group plans from their requirements. 273 For states to realize fully the long-term benefits of insurance coverage for ASD services, laws exempting self-funded, small group or individual plans from mandates would need to change. 274 Removing exemptions, however, would likely result in significant political backlash and, thus, is not likely a viable solution. Still, until mandates cover more individuals with ASDs, their impact is unlikely to be felt and the bulk of the burden will still fall to state-sponsored services.
IV. CONCLUSION
In conclusion, ASDs are complex and costly disorders that cause extraordinary financial hardships to parents and states. Current state systems providing treatment for individuals with ASDs serve too few and suffer from high staff turnover and low quality. It is in society's best interest to secure early intervention for children with ASDs to save money on costly, long-term care. Improving state-sponsored services is a laudable goal; however, these changes may create an undue financial burden on already starved state budgets. Health insurance providers have historically avoided covering treatments for children with autism through various risk-shielding techniques, and consumer protection tools are often not a cost-effective or timely way to secure treatment.
While controversial, ASD insurance reform is currently the best way to ensure treatment for individuals with ASDs. However, even liberal mandates, like Indiana's, have problems and cover less than one-third of children with ASDs. 275 There are several ways to address these problems including: eliminating age restrictions; changing diagnostic definitions to include both old and new DSM conceptualizations; allowing flexibility in
